Delayed cyclosporine administration following simulect induction does not increase acute rejection in renal transplant recipients.

被引：0
|
作者：
Pelletier, RP [1 ]
Bumgardner, GL [1 ]
Davies, EA [1 ]
Elkhammas, EA [1 ]
Henry, ML [1 ]
Ferguson, RM [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
176
引用
收藏
页码：S158 / S159
页数：2
相关论文
共 50 条
  • [21] Acute bone edema in renal transplant recipients.
    Pilmore, HL
    Walker, RJ
    KIDNEY INTERNATIONAL, 1996, 50 (04) : 1419 - 1419
  • [22] New study shows simulect reduces acute rejection and increases graft survival in diabetic renal transplant recipients
    不详
    DIALYSIS & TRANSPLANTATION, 2000, 29 (12) : 769 - 770
  • [23] Consequences and Pattern of Injury Following Late Acute Cellular Rejection in Liver Transplant Recipients.
    Mu, Y.
    Abt, P. L.
    Levine, M. H.
    Olthoff, K. M.
    Shaked, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 265 - 265
  • [24] Do early cyclosporine levels affect the incidence of acute rejection in renal transplant recipients?
    Johnson, EM
    Canafax, DM
    Gillingham, K
    Schmidt, W
    Pandian, K
    Najarian, JS
    Matas, AJ
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (02) : 879 - 879
  • [25] Basiliximab allows for delayed calcineurin inhibitor initiation and preserves renal function without increasing acute rejection in liver transplant recipients.
    Taber, DJ
    Baillie, GM
    Lin, A
    Rogers, J
    Chavin, KD
    Baliga, PK
    HEPATOLOGY, 2002, 36 (04) : 661A - 661A
  • [26] Infections Following Rejection Therapies in Solid Organ Transplant Recipients.
    Gupta, S.
    Gea-Banacloche, J.
    Me, H.
    Chascsa, D. M.
    Vikram, H. R.
    Yaman, R.
    Kodali, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 643 - 644
  • [27] Thymoglobulin reverses refractory acute rejection in kidney transplant recipients.
    Squiers, EC
    Kano, J
    Horn, HR
    BergerMoran, H
    Tesi, RJ
    Gaston, RS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3274 - A3274
  • [28] Thymoglobulin induction therapy does not increase risk of BK virus replication in kidney transplant recipients.
    Wong, WC
    Hirsch, HH
    Fujimoto, K
    Pascual, M
    Doran, MT
    Delvecchio, AM
    Cosimi, AB
    Tolkoff-Rubin, N
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 197 - 197
  • [29] Thymoglobulin is effective in reversing resistant acute rejection in transplant recipients.
    Schroeder, TJ
    Kano, J
    Horn, HR
    BergerMoran, H
    First, MR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3379 - A3379
  • [30] Cyclosporine increases soluble P-selectin in renal transplant recipients.
    Schrama, YC
    van Dam, T
    Fijnheer, R
    Hene, RJ
    Rabelink, TA
    TRANSPLANTATION, 2000, 69 (08) : S221 - S221
12345